Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 126, Issue 4
July 23 2015
Issue Cover

Table of Contents

EDITORIAL

Introduction to a series of reviews on chronic lymphocytic leukemia
Clinical Trials & Observations
John C. Byrd
View Articletitled, Introduction to a series of reviews on chronic lymphocytic leukemia

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
TWEAKing for a fight with GVHD
David J. MacEwan
View Articletitled, TWEAKing for a fight with GVHD
INSIDE BLOOD COMMENTARY
The wacky hypercoagulable state of malignancy
Clinical Trials & Observations
Alok A. Khorana
View Articletitled, The wacky hypercoagulable state of malignancy
INSIDE BLOOD COMMENTARY
Balancing bleeding in brain metastases
Clinical Trials & Observations
Lisa Baumann Kreuziger
View Articletitled, Balancing bleeding in brain metastases
INSIDE BLOOD COMMENTARY
Platelet secretion paves the way
Yunjie Huang,Sidney W. Whiteheart
View Articletitled, Platelet secretion paves the way
INSIDE BLOOD COMMENTARY
Warfarin pharmacogenomics and African ancestry
Elvin T. Price
View Articletitled, Warfarin pharmacogenomics and African ancestry

PLENARY PAPER

TRANSPLANTATION
Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD
Martin Chopra,Andreas Brandl,Daniela Siegmund,Anja Mottok,Viktoria Schäfer,Marlene Biehl,Sabrina Kraus,Carina A. Bäuerlein,Miriam Ritz,Katharina Mattenheimer,Stefanie Schwinn,Axel Seher,Thomas Grabinger,Hermann Einsele,Andreas Rosenwald,Thomas Brunner,Andreas Beilhack,Harald Wajant
View Articletitled, Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD
Supplemental data

REVIEW SERIES

Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia
Clinical Trials & Observations
Romain Guièze,Catherine J. Wu
View Articletitled, Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia

REVIEW SERIES

Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification
Clinical Trials & Observations
Paolo Strati,Tait D. Shanafelt
View Articletitled, Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification

REVIEW SERIES

Initial treatment of CLL: integrating biology and functional status
Clinical Trials & Observations
Nitin Jain,Susan O’Brien
View Articletitled, Initial treatment of CLL: integrating biology and functional status

REVIEW SERIES

Targeted therapies in CLL: mechanisms of resistance and strategies for management
Clinical Trials & Observations
Jennifer A. Woyach,Amy J. Johnson
View Articletitled, Targeted therapies in CLL: mechanisms of resistance and strategies for management

REVIEW SERIES

A drive through cellular therapy for CLL in 2015: allogeneic cell transplantation and CARs
Clinical Trials & Observations
Anthony Mato,David L. Porter
View Articletitled, A drive through cellular therapy for CLL in 2015: allogeneic cell transplantation and CARs

CLINICAL TRIALS AND OBSERVATIONS

Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome
Clinical Trials & Observations
Theodore E. Warkentin,Richard J. Cook,Ravi Sarode,Debi A. Sloane,Mark A. Crowther
View Articletitled, Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome
Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study
Clinical Trials & Observations
Jessica Donato,Federico Campigotto,Erik J. Uhlmann,Erika Coletti,Donna Neuberg,Griffin M. Weber,Jeffrey I. Zwicker
View Articletitled, Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study
A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4)
Clinical Trials & Observations Brief Report
Philip Young-Ill Choi,Fernando Roncolato,Xavier Badoux,Sundra Ramanathan,Shir-Jing Ho,Beng H. Chong
View Articletitled, A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4)
Supplemental data

IMMUNOBIOLOGY

New role for the (pro)renin receptor in T-cell development
Brief Report
Sabrina Geisberger,Ulrike Maschke,Matthias Gebhardt,Markus Kleinewietfeld,Arndt Manzel,Ralf A. Linker,Ann Chidgey,Ralf Dechend,Genevieve Nguyen,Oliver Daumke,Dominik N. Muller,Mark D. Wright,Katrina J. Binger
View Articletitled, New role for the (pro)renin receptor in T-cell development
Supplemental data

LYMPHOID NEOPLASIA

Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides
Laura Y. McGirt,Peilin Jia,Devin A. Baerenwald,Robert J. Duszynski,Kimberly B. Dahlman,John A. Zic,Jeffrey P. Zwerner,Donald Hucks,Utpal Dave,Zhongming Zhao,Christine M. Eischen
View Articletitled, Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides
Supplemental data

PLATELETS AND THROMBOPOIESIS

Regulation of actin polymerization by tropomodulin-3 controls megakaryocyte actin organization and platelet biogenesis
Zhenhua Sui,Roberta B. Nowak,Chad Sanada,Stephanie Halene,Diane S. Krause,Velia M. Fowler
View Articletitled, Regulation of actin polymerization by tropomodulin-3 controls megakaryocyte actin organization and platelet biogenesis
Supplemental data
Platelet geometry sensing spatially regulates α-granule secretion to enable matrix self-deposition
Yumiko Sakurai,Jennifer L. Fitch-Tewfik,Yongzhi Qiu,Byungwook Ahn,David R. Myers,Reginald Tran,Meredith E. Fay,Lingmei Ding,Paul W. Spearman,Alan D. Michelson,Robert Flaumenhaft,Wilbur A. Lam
View Articletitled, Platelet geometry sensing spatially regulates α-granule secretion to enable matrix self-deposition
Supplemental data

THROMBOSIS AND HEMOSTASIS

Race influences warfarin dose changes associated with genetic factors
Clinical Trials & Observations
Nita A. Limdi,Todd M. Brown,Qi Yan,Jonathan L. Thigpen,Aditi Shendre,Nianjun Liu,Charles E. Hill,Donna K. Arnett,T. Mark Beasley
View Articletitled, Race influences warfarin dose changes associated with genetic factors

TRANSPLANTATION

Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease
Byung-Su Kim,Hidekazu Nishikii,Jeanette Baker,Antonio Pierini,Dominik Schneidawind,Yuqiong Pan,Andreas Beilhack,Chung-Gyu Park,Robert S. Negrin
View Articletitled, Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease
Supplemental data

BLOOD WORK

Disseminated blastic plasmacytoid dendritic cell neoplasm
Sanam Loghavi,Joseph D. Khoury
View Articletitled, Disseminated blastic plasmacytoid dendritic cell neoplasm
Pseudoplatelets in acute myeloid leukemia
Randall Y. Chan,Maria Vergara-Lluri
View Articletitled, Pseudoplatelets in acute myeloid leukemia

CORRESPONDENCE

White blood cell counts and thrombosis in polycythemia vera: a subanalysis of the CYTO-PV study
Clinical Trials & Observations
Tiziano Barbui,Arianna Masciulli,Maria Rosa Marfisi,Giovanni Tognoni,Guido Finazzi,Alessandro Rambaldi,Alessandro Vannucchi
View Articletitled, White blood cell counts and thrombosis in polycythemia vera: a subanalysis of the CYTO-PV study
Improved outcomes associated with hematopoietic stem cell transplantation for patients with juvenile myelomonocytic leukemia
Quan Zhao,Kris Michael Mahadeo,Neena Kapoor,Hisham Abdel-Azim
View Articletitled, Improved outcomes associated with hematopoietic stem cell transplantation for patients with juvenile myelomonocytic leukemia
All Issues

Advertisement intended for health care professionals

Time for a new prognostic score in CLL?
Azab AK, Runnels JM, Pitsillides C, et al. CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood. 2009;113(18):4341-4351.
Garcia E, Horowitz AM, Franklin K, Mader M, Kaur S. Outcomes of veterans with FMS-like tyrosine kinase 3 mutated (mFLT3) acute myeloid leukemia (AML) treated with novel FLT3 inhibitors (FLT3i) within the Veterans Health Administration (VHA) [abstract]. Blood. 2023;142(suppl 1):7414.
Soluble Glycoprotein VI Predicts Abdominal Aortic Aneurysm Growth Rate and is a Novel Therapeutic Target
Murine models of erythroid 5ALA synthesis disorders and their conditional synthetic lethal dependency on pyridoxine

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals